FREDERICK, Md., March 26, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global company specializing in disinfection and decontamination solutions, today announced it will report results for the fourth quarter ended December 31, 2025, after the close of the financial markets on Tuesday, March 31, 2026, and will hold a conference call at 4:30 p.m. ET that day. To participate in the call by phone, dial (888) 506-0062 approximately five minutes prior to the scheduled st ...

European Union Market Expansion Advances with Official AuthorizationFREDERICK, Md., March 25, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, announced today that its Binary Ionization Technology has received formal approval from the Dutch regulatory authority Board (“ctgb”) for the Authorization of Plant Protection Products and Biocides, marking the Company's first product authorization within a European Un ...

FREDERICK, Md., March 24, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today revealed that a leading Mexican dairy manufacturer has secured ongoing SteraMist iHP services to maintain its high-standard facility sanitation. TOMI’s long-standing relationship with DisinfectCare has facilitated the implementation of SteraMist service at a major dairy facility in Mexico. Prior to purchase, DisinfectCare conduct ...

FREDERICK, Md., March 18, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, is accelerating its expansion into the food safety sector by delivering unprecedented operational savings of up to 95%. As global supply chains face mounting pressure to eliminate pathogens such as Salmonella, Listeria, and E. coli, the industry is rapidly transitioning from legacy chemical applications toward the advanced, science-dri ...

Strategic Growth Driven by SteraMist iHP Technology Placements in Premier Healthcare and Pathogen Research FacilitiesFREDERICK, Md., March 16, 2026 (GLOBE NEWSWIRE) -- TOMI Environmental Solutions, Inc.® (“TOMI”) (NASDAQ: TOMZ), a global leader in disinfection and decontamination solutions, today announced expansion of its presence across Canada following a series of strategic wins from late 2025 into early 2026. These placements include integrations within Canada’s largest health research organization and ...

Core Viewpoint - TOMI Environmental Solutions (TOMZ) has entered into a strategic partnership with Total Clean Air (TCA), designating TCA as its Preferred European Partner for the SteraMist iHP decontamination technology, aimed at addressing the growing demand for infection control in various sectors [1] Group 1: Partnership Details - TCA will be the primary partner for sales, service, and technical support for TOMZ's SteraMist iHP technology across the United Kingdom and the European Union [1] - This partnership aims to create a streamlined infrastructure to meet the increasing demand for aseptic processing and high-level decontamination in the life sciences, pharmaceutical, and controlled environment sectors [1] Group 2: Market Potential - The market for infection control in the UK is projected to exceed $6 billion by 2031, indicating significant growth potential in this sector [1] - TCA will manage the full customer lifecycle for SteraMist iHP, from initial demonstrations to long-term maintenance, enhancing customer engagement and service delivery [1]

Core Insights - TOMI Environmental Solutions, Inc. has formed a strategic partnership with Total Clean Air, designating TCA as its Preferred European Partner for SteraMist iHP decontamination technology [1][2] Company Overview - TOMI is a global leader in disinfection and decontamination solutions, utilizing its Binary Ionization Technology (BIT) platform to produce a germ-killing aerosol [6] - TCA specializes in cleanroom design, build, and validation, operating across pharmaceutical, life sciences, and healthcare sectors [9] Partnership Details - TCA will handle sales, service, and technical support for TOMI's SteraMist iHP across the UK and EU, addressing the growing demand for aseptic processing and high-level decontamination [2][3] - The UK infection control market is projected to exceed $6 billion by 2031, indicating significant growth potential for both companies [2] Market Dynamics - The UK sterility testing market is expected to grow at a 14% CAGR through 2035, driven by regulatory requirements and a shift towards rapid testing methods [3] - The partnership aims to enhance compliance with EU GMP Annex 1, providing in-region technical support and validation [3] Service Infrastructure - TCA will maintain consignment stock of SteraMist iHP equipment and consumables, offering annual calibration and routine inspections to ensure high-quality service [4] - A demonstration and trial program will be established at TCA's UK showroom, allowing hands-on evaluation of SteraMist equipment [5]

Core Viewpoint - TOMI Environmental Solutions, Inc. has received official authorization for its Binary Ionization Technology (BIT) solution and SteraMist iHP brand of disinfection equipment from the Health and Safety Executive (HSE) in Great Britain, marking a significant step for the company's expansion in the UK market [1][2]. Group 1: Product Approval and Market Expansion - The BIT solution is now approved as a biocidal product for use in Great Britain, including England, Scotland, and Wales, under Regulation 528/2012 GB, and also received separate approval for Northern Ireland under Regulation (EU) No. 528/2012 [1][2]. - This approval allows for the BIT solution to be used in room fogging and handheld direct spray applications as a microbial disinfectant across various sectors such as healthcare, industrial, commercial, hospitality, and institutional settings [2][3]. Group 2: Efficacy and Applications - The BIT solution has established efficacy claims in Great Britain, demonstrating effectiveness against bacteria, yeast, and viruses with specific contact times ranging from 5 to 15 minutes depending on the application method [4]. - SteraMist products utilize a low percentage of Hydrogen Peroxide to create a germ-killing aerosol, suitable for a wide range of applications including hospitals, schools, and military facilities [4][5]. Group 3: Company Background and Commitment - TOMI Environmental Solutions, Inc. is a global leader in decontamination and infection prevention, focusing on indoor surface disinfection through its BIT platform, which was developed under a defense grant in collaboration with DARPA [5][6]. - The company emphasizes its commitment to providing innovative solutions that meet rigorous compliance, safety, and efficacy standards, with optimism for further approvals in the European Union [3][5].

Core Insights - TOMI Environmental Solutions, Inc. has announced the sale of a Custom Engineered System (CES) to a pharmaceutical manufacturing organization in the UK, marking a significant step in its international growth strategy [1][5]. Group 1: Company Overview - TOMI Environmental Solutions, Inc. is a global leader in disinfection and decontamination solutions, utilizing its Binary Ionization Technology® (BIT™) platform to provide environmental solutions for indoor surface disinfection [7]. - The company's SteraMist® brand produces a germ-killing aerosol using a low percentage of Hydrogen Peroxide as its active ingredient, which is recognized for its effectiveness in various commercial structures [8]. Group 2: Partnership and Technology Integration - The CES being delivered is part of a bespoke, modular cleanroom platform designed by Total Clean Air Limited (TCA), integrating SteraMist iHP technology into TCA's cleanroom architecture, which is the first deployment of this technology within TCA's modular platform [2][4]. - This collaboration aims to create a scalable pathway for future system deployments, enhancing patient safety and operational confidence while ensuring compliance with regulatory frameworks [5][6]. Group 3: Regulatory Compliance and Market Position - TCA's modular solution aligns with UK MHRA and EMA expectations, embedding decontamination capabilities throughout the cleanroom lifecycle, which ensures long-term facility performance and operational resilience for pharmaceutical operators [3]. - The partnership reinforces TCA's position as a trusted cleanroom delivery partner, providing fully integrated solutions that span cleanroom design, containment, and validation [4].

Core Insights - TOMI Environmental Solutions, Inc. has announced the purchase of its SteraMist Hybrid System for a private research university on the East Coast, aimed at ensuring the safety and sterilization of reusable medical equipment for patient homes [1] - The facility requires a reliable decontamination solution for its sterilization room, which is crucial for meeting safety protocols for reusable medical products [2] - The integration of the SteraMist Hybrid System demonstrates its capability to meet the high standards set by healthcare organizations, marking the second sale in a $13 million pipeline for automated installation projects [3] Company Overview - TOMI Environmental Solutions, Inc. is a global leader in decontamination and infection prevention, utilizing its Binary Ionization Technology® (BIT™) platform to provide indoor surface disinfection solutions [4] - The BIT™ solution, developed under a defense grant with DARPA, uses a low percentage of Hydrogen Peroxide to create a fog of ionized Hydrogen Peroxide (iHP™), which effectively kills germs [4] - TOMI's products cater to a wide range of commercial structures, including hospitals, schools, and military facilities, as well as residential applications [5] Industry Context - The demand for reliable decontamination solutions is critical in the healthcare sector, particularly for medical devices and products that are reprocessed for patient use [2] - The successful deployment of the SteraMist Hybrid System at a research university highlights the increasing need for advanced sterilization technologies in high-stakes medical environments [3]